Nabriva Therapeutics

The 2023 Biotech Graveyard
Fierce Biotech
Tue, 10/31/23 - 11:34 am
biotech
Rubius Therapeutics
Nabriva Therapeutics
Calithera Biosciences
Goldfinch Bio
Antios Therapeutics
Magenta Therapeutics
Coda Biotherapeutics
Aristea Therapeutics
Nabriva halts R&D, lays off 40% of staff in commercial-focused pivot for survival
Fierce Biotech
Fri, 11/11/22 - 10:46 am
Nabriva Therapeutics
R&D
layoffs
Sivextro
Nabriva hit with another FDA setback with complete response letter for antibiotic Contepo
Fierce Pharma
Mon, 06/22/20 - 10:45 am
Nabriva Therapeutics
FDA
Xenleta
antibiotics
Ahead of FDA decisions on one antibiotic, Nabriva plans resubmission of another
BioCentury
Fri, 08/16/19 - 11:59 pm
Nabriva Therapeutics
antibiotics
lefmulin
Four New Drugs are Around the Corner. Here’s What You Need to Know.
Xconomy
Thu, 08/15/19 - 11:39 pm
FDA
drug approvals
AbbVie
Upadacitinib
Exondys 51
Sarepta Therapeutics
Nabriva Therapeutics
lefamulin
Roche
Rozlytrek
FDA Action Alert: Regeneron, Sanofi, Celgene
BioSpace
Mon, 06/24/19 - 07:27 pm
FDA
drug approvals
Acer Therapeutics
Edsivo
Regeneron
Sanofi
Dupixent
Celgene
Revlimid
Alexion
Soliris
Dova Pharmaceuticals
Doptelet
Nabriva Therapeutics
Contepo
Retrophin
Thiola
Nabriva's Antibiotic Contempo Turned Down by FDA Over Manufacturing Issues
BioSpace
Wed, 05/1/19 - 10:56 am
Nabriva Therapeutics
Contempo
antibiotics
FDA
drug manufacturing
Nabriva shares leap higher on antibiotic trial success
BioPharma Dive
Tue, 09/19/17 - 08:45 am
Nabriva Therapeutics
antibiotics
clinical trials
lefamulin
Antibiotics biotech Nabriva shoots for a $92M IPO
Fierce Biotech
Fri, 06/19/15 - 10:07 am
Nabriva Therapeutics
IPOs
antibiotics
lefamulin
Forest Laboratories and Nabriva sign development agreement for anti-bacterial drug
Proactive Investors
Sun, 06/3/12 - 11:34 am
Nabriva Therapeutics
Forest Labs
BC-3781
antibiotics
Forest Laboratories and Nabriva Therapeutics Sign Agreement
Yahoo
Fri, 06/1/12 - 10:28 am
Forest Labs
Nabriva Therapeutics
BC-3781
M&A